Expression of recombinant human interferon-γ with antiviral activity in the Bi-cistronic baculovirus-insect/larval system

  • CHEN Wen-Shuo
    Institute of Molecular Medicine, National Tsing Hua University
  • VILLAFLORES Oliver B.
    Department of Chemistry, Chung Yuan Christian University
  • JINN Tzyy-Rong
    Graduate Institute of Chinese Medical Science, China Medical University
  • CHAN Ming-Tsair
    Institute of BioAgricultural Sciences, Academia Sinica
  • CHANG Yen-Chung
    Institute of Molecular Medicine, National Tsing Hua University
  • WU Tzong-Yuan
    Department of Bioscience Technology, Chung Yuan Christian University R&D Center for Membrane Technology, Chung Yuan Christian University

書誌事項

タイトル別名
  • Expression of Recombinant Human Interferon-.GAMMA. with Antiviral Activity in the Bi-Cistronic Baculovirus-Insect/Larval System
  • Expression of recombinant human interferon g with antiviral activity in the Bi cistronic baculovirus insect larval system

この論文をさがす

抄録

A bi-cistronic baculovirus-insect/larval system containing a polyhedron promoter, an internal ribosome entry site (IRES), and an egfp gene was developed as a cost-effective platform for the production of recombinant human interferon gamma (rhIFN-γ). There was no significant difference between the amounts of rhIFN-γ produced in the baculovirus-infected Spodoptera frugiferda 21 cells grown in serum-free medium and the serum-supplemented medium, while the Trichoplusia ni (T. ni) and Spodoptera exigua (S. exigua) larvae afforded rhIFN-γ amounting to 1.08±0.04 and 9.74±0.35 μg/mg protein respectively. The presence of non-glycosylated and glycosylated rhIFN-γ was confirmed by immunoblot and lectin blot. The immunological activity of purified rhIFN-γ, with 96% purity by Nickel (II)-nitrilotriacetic acid (Ni-NTA) affinity chromatography, was similar to that commercially available. Moreover, the rhIFN-γ protein from T. ni had more potent antiviral activity. These findings suggest that this IRES-based expression system is a simple and inexpensive alternative for large-scale protein production in anti-viral research.

収録刊行物

参考文献 (81)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ